ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,720Medicare Part D Prescriptions Filled, Including Refills

Rank: 146 out of 1006

$518K Total Retail Price of All Prescriptions

Rank: 210 out of 1006

472 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 472 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 472 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 8,086 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 470 443 1 3
SIMVASTATIN 376 347 2 1
HYDROCHLOROTHIAZIDE 319 306 3 11
METOPROLOL TARTRATE 296 277 4 7
LEVOTHYROXINE SODIUM 294 259 5 2
ATORVASTATIN CALCIUM 287 271 6 5
FUROSEMIDE 286 272 7 6
ALENDRONATE SODIUM 236 236 8 29
ATENOLOL 202 199 9 13
AMLODIPINE BESYLATE 188 183 10 4
METFORMIN HCL ER 180 164 11 56
METOPROLOL SUCCINATE 153 137 12 12
GLYBURIDE 153 132 R 12 65
ALLOPURINOL 145 138 14 31
DONEPEZIL HCL 131 131 15 17
TRIAMTERENE-HCTZ 120 119 16 58
LIPITOR 113 111 17 47
FLUTICASONE PROPIONATE 110 102 18 55
TAMSULOSIN HCL 107 107 19 23
DIOVAN 102 94 20 16
ENALAPRIL MALEATE 95 95 21 83
OMEPRAZOLE 94 78 22 9
CITALOPRAM HBR 92 80 23 24
GABAPENTIN 90 86 24 20
JANUVIA 89 85 25 49
HYDROCODONE-ACETAMINOPHEN 87 79 S3 26 25
ZOLPIDEM TARTRATE 83 70 27 14
LOSARTAN POTASSIUM 83 83 27 22
WARFARIN SODIUM 79 79 29 8
CRESTOR 77 73 30 18
LOVASTATIN 76 76 31 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 65 32 38
PAROXETINE HCL 66 63 33 62
NEXIUM 66 59 33 28
PRAVASTATIN SODIUM 66 63 33 15
FINASTERIDE 65 65 36 76
METFORMIN HCL 62 43 37 10
PREDNISONE 59 57 38 33
POTASSIUM CHLORIDE 56 47 39 30
FLOVENT HFA 56 56 39 261
DIOVAN HCT 51 41 41 60
PROAIR HFA 51 47 41 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 31, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.